Immune Stimulation With Recombinant Human Granulocyte Colony-Stimulating Factor for Coronavirus Disease 2019 (COVID-19)-Beware of Blind Spots

JAMA Intern Med. 2021 Jan 1;181(1):78-80. doi: 10.1001/jamainternmed.2020.5536.

Nuala J Meyer^{1

2}, Robert B Lindell^{2

3}, E John Wherry^{2

4

5}

¹ Division of Pulmonary, Allergy, and Critical Care Medicine and Center for Translational Lung Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
² Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
³ Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia.
⁴ Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
⁵ Parker Institute for Cancer Immunotherapy at the University of Pennsylvania Perelman School of Medicine, Philadelphia.

No abstract available

Publication types